COLLEGIUM PHARMACEUTICAL INC (COLL)
US19459J1043 - Common Stock
Taking everything into account, COLL scores 6 out of 10 in our fundamental rating. COLL was compared to 194 industry peers in the Pharmaceuticals industry. While COLL has a great profitability rating, there are quite some concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on COLL.
1. Profitability
1.1 Basic Checks
COLL had positive earnings in the past year.
In the past year COLL had a positive cash flow from operations.
In multiple years COLL reported negative net income over the last 5 years.
Each year in the past 5 years COLL had a positive operating cash flow.
1.2 Ratios
COLL has a better Return On Assets (5.42%) than 88.54% of its industry peers.
Looking at the Return On Equity, with a value of 37.82%, COLL belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
COLL has a Return On Invested Capital of 10.46%. This is amongst the best in the industry. COLL outperforms 89.58% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for COLL is significantly below the industry average of 42.22%.
The 3 year average ROIC (8.70%) for COLL is below the current ROIC(10.46%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 37.82% | ||
| ROIC | 10.46% |
ROA(3y)4.14%
ROA(5y)1.83%
ROE(3y)15.68%
ROE(5y)7.1%
ROIC(3y)8.7%
ROIC(5y)N/A
1.3 Margins
COLL has a Profit Margin of 14.78%. This is amongst the best in the industry. COLL outperforms 90.10% of its industry peers.
COLL's Profit Margin has been stable in the last couple of years.
With an excellent Operating Margin value of 32.29%, COLL belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
COLL's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 62.36%, COLL is doing good in the industry, outperforming 68.23% of the companies in the same industry.
COLL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 32.29% | ||
| PM (TTM) | 14.78% | ||
| GM | 62.36% |
OM growth 3Y19.53%
OM growth 5YN/A
PM growth 3Y-0.58%
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y7.07%
2. Health
2.1 Basic Checks
COLL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for COLL has been reduced compared to 1 year ago.
The number of shares outstanding for COLL has been reduced compared to 5 years ago.
Compared to 1 year ago, COLL has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.01, we must say that COLL is in the distress zone and has some risk of bankruptcy.
COLL has a Altman-Z score (1.01) which is in line with its industry peers.
The Debt to FCF ratio of COLL is 4.51, which is a neutral value as it means it would take COLL, 4.51 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 4.51, COLL belongs to the best of the industry, outperforming 88.02% of the companies in the same industry.
A Debt/Equity ratio of 3.43 is on the high side and indicates that COLL has dependencies on debt financing.
COLL has a Debt to Equity ratio of 3.43. This is amonst the worse of the industry: COLL underperforms 84.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.43 | ||
| Debt/FCF | 4.51 | ||
| Altman-Z | 1.01 |
ROIC/WACC1.15
WACC9.08%
2.3 Liquidity
COLL has a Current Ratio of 0.97. This is a bad value and indicates that COLL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.97, COLL is doing worse than 85.94% of the companies in the same industry.
A Quick Ratio of 0.88 indicates that COLL may have some problems paying its short term obligations.
With a Quick ratio value of 0.88, COLL is not doing good in the industry: 82.81% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.97 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 3566.67% over the past year.
The Earnings Per Share has been growing by 15.79% on average over the past years. This is quite good.
Looking at the last year, COLL shows a quite strong growth in Revenue. The Revenue has grown by 9.63% in the last year.
The Revenue has been growing by 15.11% on average over the past years. This is quite good.
EPS 1Y (TTM)3566.67%
EPS 3Y15.79%
EPS 5YN/A
EPS Q2Q%203.77%
Revenue 1Y (TTM)9.63%
Revenue growth 3Y22.28%
Revenue growth 5Y15.11%
Sales Q2Q%16.52%
3.2 Future
The Earnings Per Share is expected to grow by 46.17% on average over the next years. This is a very strong growth
COLL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -6.60% yearly.
EPS Next Y431.83%
EPS Next 2Y141.51%
EPS Next 3Y83.6%
EPS Next 5Y46.17%
Revenue Next Year11.19%
Revenue Next 2Y14.55%
Revenue Next 3Y10.44%
Revenue Next 5Y-6.6%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 5.53 indicates a rather cheap valuation of COLL.
Compared to the rest of the industry, the Price/Earnings ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 94.79% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.96, COLL is valued rather cheaply.
The Price/Forward Earnings ratio is 4.42, which indicates a rather cheap valuation of COLL.
95.83% of the companies in the same industry are more expensive than COLL, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.82. COLL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.53 | ||
| Fwd PE | 4.42 |
4.2 Price Multiples
COLL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. COLL is cheaper than 95.31% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, COLL is valued cheaply inside the industry as 96.35% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.1 | ||
| EV/EBITDA | 4.78 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COLL has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as COLL's earnings are expected to grow with 83.60% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y141.51%
EPS Next 3Y83.6%
5. Dividend
5.1 Amount
COLL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
COLLEGIUM PHARMACEUTICAL INC
NASDAQ:COLL (11/21/2024, 7:15:26 PM)
After market: 29.0501 -1.36 (-4.47%)30.41
+0.41 (+1.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap980.72M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.53 | ||
| Fwd PE | 4.42 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.01
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 37.82% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 32.29% | ||
| PM (TTM) | 14.78% | ||
| GM | 62.36% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.43 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.97 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3566.67%
EPS 3Y15.79%
EPS 5Y
EPS Q2Q%
EPS Next Y431.83%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.63%
Revenue growth 3Y22.28%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y